While others chase compliance, we engineer regulatory victory. Fortune 500 leaders and emerging innovators trust CWM Solutions to crush delays, force clean inspections, and dominate new markets — from FDA to EMA, PMDA, ANVISA, NMPA and beyond.
We don't just implement QMS. We build unstoppable quality systems that pass first time across FDA, EMA, PMDA, ANVISA, NMPA — and keep you bulletproof long after.
We design, build, and implement Quality Management Systems from the ground up — or modernize your existing infrastructure to meet current GxP and regulatory standards across the full product lifecycle.
Complete management of controlled document systems — SOPs, policies, technical documents. Veeva Vault and QDocs expertise with style guide development, governance frameworks, and platform training.
Systematic Corrective and Preventive Action programs — from root cause investigation through effectiveness verification. On time, on standard, and inspection-ready.
Structured change management programs ensuring quality system changes are evaluated, approved, and implemented without introducing compliance risk or disrupting ongoing operations.
Full training programs tailored to your quality systems and platforms. Curriculum design, delivery, training records management, and ongoing administration within your QMS environment.
Ongoing Quality Assurance responsibilities, continuous improvement, periodic reviews, metric reporting, and audit preparation to sustain peak compliance across your quality systems.
4–7 months faster to market. 100% first-pass approval rate. 6+ major regulatory markets conquered. These aren't promises — they're our track record. As an SBA-certified WOSB, we combine boutique precision with world-class regulatory mastery.
You get senior regulatory expertise on day one — no handoffs, no junior consultants learning on your dime. Direct access means faster answers and zero delays.
FDA. EMA. PMDA. ANVISA. NMPA. We've engineered approvals across six major markets — and counting. One partner, unlimited reach.
Our 100% first-pass success rate isn't a tagline — it's our operating standard. We don't submit until it's bulletproof.
Every week of delay costs revenue. We run lean, aggressive timelines that compress approvals without cutting corners — because speed and compliance aren't opposites.
Real-time enforcement actions, warning letters, drug recalls, and regulatory updates — curated for pharma and biotech quality professionals. Powered by openFDA and FDA public data feeds.
With 15 years of extensive experience in the pharmaceutical and biotech industries, Holly specializes in the review, control, and implementation of controlled GxP documentation — spanning Quality Systems, Compliance, and Analytical Method Development. She played a pivotal role in establishing the original Technical Services department dedicated to supporting Quality Control (QC) analytical test methods and validations.
Currently focused on enhancing electronic document management systems — particularly Veeva QualityDocs and Veeva QMS — Holly’s efforts consistently center on streamlining processes to improve efficiency and accuracy, while ensuring compliance and fostering a culture of quality excellence. She is passionate about leveraging technology to advance quality management practices and committed to driving continuous improvement within the industry.
Every engagement is confidential. Client names are withheld — outcomes are not. These represent real work, real timelines, real results.
A commercial-stage pharma company lacked audit-ready documentation ahead of a scheduled FDA pre-approval inspection. SOPs were outdated and change control processes were entirely manual.
Designed and implemented a GxP document control framework in Veeva QualityDocs. Standardized SOP templates, established DCC workflows, and trained site personnel on full document lifecycle management.
A clinical-stage biotech received a 483 observation citing inadequate CAPA documentation and incomplete root cause analysis. Regulatory response deadline was 15 business days.
Rebuilt CAPA processes within the client's QMS, authored the FDA response package, and implemented a corrective action tracking workflow aligned to 21 CFR Part 211.
A startup medical device company needed a Quality Systems foundation to support ISO 13485 certification and future FDA 510(k) submission. No existing QS infrastructure was in place.
Built the QS framework from scratch — SOPs, quality manual, document control procedures, and training records — aligned to ISO 13485 and 21 CFR Part 820.
CWM Solutions specializes exclusively in life sciences quality management. Our domain spans the full range of regulated industries where quality is a patient safety imperative — not a checkbox.
We understand the regulatory landscape, platform ecosystems, and operational realities of organizations at every development stage — from clinical-stage to commercial launch.
Discuss Your Needs →Small molecule, biologics, and combination products. Full GxP quality lifecycle from development through commercial operations.
Clinical-stage through commercial launch QMS design and operations for biotech organizations of any size.
ISO 13485-aligned quality systems and FDA 21 CFR Part 820 compliance for device and combination product manufacturers.
Emerging modality quality frameworks built for the regulatory novelty and complexity of CGT development programs.
Every CWM Solutions engagement follows a structured, outcome-driven methodology. Proven frameworks, adapted precisely to your context, with measurable results at every phase.
Gap analysis of your current quality infrastructure against applicable regulatory standards and your organization's maturity goals.
Custom roadmap — system architecture, process design, and a realistic implementation plan with clear, measurable milestones.
Hands-on implementation: QMS build, document migration, platform configuration, CAPA workflows, training delivery, and validation.
Steady-state support, continuous improvement, and periodic health checks to keep your QMS compliant and inspection-ready.
Tell us your market. Your timeline. Your biggest regulatory headache. We'll show you exactly how we engineer approval — faster, cleaner, globally.
We respond within one business day · [email protected] · All inquiries are confidential.